by admin | Oct 16, 2026 | Careers
ABOUT EXOGENUS THERAPEUTICS Exogenus Therapeutics is a biotechnology company developing multifactorial, disease-modifying biologics for regenerative medicine. Our lead programme, Exo-101, is an extracellular-vesicle-enriched secretome in development for knee...
by admin | Oct 15, 2026 | Careers
ABOUT EXOGENUS THERAPEUTICS Exogenus Therapeutics is a biotechnology company developing multifactorial, disease-modifying biologics for regenerative medicine. Our lead programme, Exo-101, is an extracellular-vesicle-enriched secretome in development for knee...
by admin | Sep 15, 2026 | News
Selected among Europe’s leading life sciences executives, Exogenus Therapeutics CEO Joana Simões Correia has been named a finalist in the Women-Led Business of the Year category at the European Lifestars Awards 2026, organised by Informa Connect, the...
by admin | Jan 12, 2026 | News
Exogenus Therapeutics is thrilled to announce the granting of a new patent in the United States, marking a major milestone in the company’s global expansion. This is the second region to recognize the patent family titled: “Compositions comprising small extracellular...
by admin | May 5, 2025 | News
We are pleased to announce that Exogenus Therapeutics has been granted another patent, now in Europe! This is the fifth region to recognize the patent family titled “Use of umbilical cord blood-derived exosomes for tissue repair.” This patent family has also been...
